1/1
Safety of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis: an integrated analysis of eight clinical trials
media
posted on 2023-05-12, 04:29 authored by Adis Journals on behalf of:, Linda Stein Gold, Diamant Thaçi, Jacob P. Thyssen, Melinda Gooderham, Vivian Laquer, Angela Moore, Chitra R. Natalie, Fangyi Zhao, Eric Meskimen, Hany Elmaraghy, Sonia Montmayeur, Gaia Gallo, Gemma Jimenez, Marjolein de Bruin-WellerArticle full text
The above video abstract and plain language summary represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2023
